{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baltimore",
      "state": "MD",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67462",
      "recalling_firm": "Lupin Pharmaceuticals Inc.",
      "address_1": "111 S Calvert St Fl 21st",
      "address_2": "N/A",
      "postal_code": "21202-6174",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1187-2014",
      "product_description": "Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml,  20 mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India,  NDC 27437-207-03.",
      "product_quantity": "5,172 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.",
      "recall_initiation_date": "20140127",
      "center_classification_date": "20140402",
      "termination_date": "20150512",
      "report_date": "20140409",
      "code_info": "Lot #s: F300736 Exp. February 2015, F300740 Exp. February 2015, F300741 Exp. February 2015"
    }
  ]
}